Note: Ingredients listed on restricted chemical lists
General Information
Version
2.0
Revision date
2023-10-20
Product name
Viramune tablets
Product Synonyms
Viramune® 200 mg tablets with active ingredient: Nevirapine Anhydrous
1.2.1 Relevant identified uses
Pharmaceutical
1.2.2. Uses advised against
Safety Data Sheet only for the professional user
supplier name
Boehringer Ingelheim Pharmaceuticals Inc
Emergency telephone
+1 703-527-3887, +1 703-741-5970
Icons in SDS
Company Information
company name
Boehringer Ingelheim Pharmaceuticals Inc
e-mail address of the competent person responsible for the Safety Data Sheet
EHS-Services@Boehringer-Ingelheim.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Signal word
Warning
Hazard statements
H302 Harmful if swallowed.
Prevention
P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product.
Response
P301 + P312 + P330 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. Rinse mouth.
Disposal
P501 Dispose of contents/ container to an approved waste dis- posal plant.
Other hazards
The pharmacological effect of the medicament has to be considered (see package leaflet) This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS)
2.1 Classification of the substance or mixture
1910.1200) Acute toxicity (Oral)
